FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology, and is intended to determine indications for the treatment of primary open-angle glaucoma with the help of the brain-derived neurotrophic factor (BDNF). To determine the indications for the treatment of primary open-angle glaucoma with the help of BDNF in the lachrymal fluid (LF) of the patient, the concentration of BDNF is determined by the method of non-competitive enzyme immunoassay (EIA). When the concentration of BDNF in LF is less than 63 picograms/ml (pg/ml), its administration is shown.
EFFECT: use of the invention provides for the determination of indications for the treatment of primary open-angle glaucoma with the help of BDNF.
4 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINATION OF INDICATIONS FOR INTRAVITREAL INJECTION OF CILIARY NEUROTROPHIC FACTOR DURING TREATMENT OF EYE VISUAL-NERVE APPARATUS DISEASES | 2016 |
|
RU2617066C1 |
| METHOD FOR CORRECTION OF NEUROTROPHILIC CHANGES IN PATIENTS WITH PRIMARY OPEN-ANGLE GLAUCOMA AFTER CORONAVIRUS INFECTION | 2023 |
|
RU2814770C1 |
| METHOD FOR TREATMENT OF GLAUCOMOUS OPTIC NEUROPATHY BY MEANS OF TRANSPLANTATION OF 3D CELLULAR CULTURE OF MULTIPOTENT MESENCHIMAL SCLERAL SULCUS STEM CELLS | 2016 |
|
RU2623646C1 |
| METHOD OF ESTIMATING THE EFFICIENCY OF NEURORETIN PROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA BASED ON DETERMINATION OF THE NEUROTROPHIC FACTOR OF THE BRAIN | 2018 |
|
RU2681934C1 |
| METHOD FOR ASSESSING THE EFFICACY OF NEURORETINOPROTECTION OF PRIMARY OPEN-ANGLE GLAUCOMA ON BASIS OF DETERMINING RATIO OF NEURAL MARKERS | 2018 |
|
RU2681654C1 |
| METHOD OF PREVENTION OF THE PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2799582C1 |
| METHOD FOR PREDICTING THE RISK OF PRIMARY OPEN-ANGLE GLAUCOMA | 2020 |
|
RU2752031C1 |
| METHOD OF MAKING PROGNOSIS OF COURSE OF GLAUCOMATOUS OPTICAL NEUROPATHY | 2004 |
|
RU2281023C2 |
| METHOD FOR PREDICTING THE RISK OF PROGRESSION OF PRIMARY OPEN-ANGLE GLAUCOMA | 2023 |
|
RU2804591C1 |
| METHOD OF TWO-STAGE SURGICAL TREATMENT OF CATARACT IN COMBINATION WITH PRIMARY OPEN-ANGLE GLAUCOMA | 2022 |
|
RU2796869C1 |
